Oncology

Risk of short-term prostate-specific antigen recurrence and failure in patients with prostate cancer

Nov 19, 2023

1. For patients with unfavorable nonmetastatic prostate cancer aged above 70 years, PSA levels...

Concurrent stereotactic radiation with antibody-drug conjugates in the treatment of brain metastases is associated with a greater risk of symptomatic radiation necrosis

Nov 14, 2023

Bookmark1. A greater percentage of patients who received concurrent stereotactic radiation therapy...

Amivantamab Plus Chemotherapy with and without Lazertinib in EGFR-mutant NSCLC

Nov 14, 2023

Bookmark1. Progression-free survival was 6.3 months for the amivantamab–chemotherapy group, 8.3...

Pyrotinib in combination with trastuzumab and docetaxel promising for HER2 positive metastatic breast cancer

Nov 10, 2023

Bookmark1. This phase 3 randomised trial demonstrated that compared with placebo in combination...

Sacituzumab govitecan shows survival benefit in endocrine-resistant hormone-positive metastatic breast cancer

Nov 9, 2023

Bookmark1. Median overall survival increased by 3.2 months in the sacituzumab govitecan group...

Spiritual health may be high among cancer patients in drug clinical trials

Nov 8, 2023

Bookmark1. In this cross-sectional study, cancer patients enrolled in clinical trials demonstrated...

Selpercatinib vs Chemotherapy and Pembrolizumab in RET Positive NSCLC

Nov 7, 2023

Bookmark1. The progression-free survival was 24.8 months in the selpercatinib group vs 11.2 months in the control group (chemotherapy ± pembrolizumab), with an HR of 0.46. 2. Grade ≥3 adverse events occurred in 70% vs 57%...

Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions

Oct 31, 2023

Bookmark1. Median progression-free survival was 11.4 months in the amivantamab–chemotherapy group...

Treatment of metastatic uveal melanoma with tebentafusp provides greater overall survival and progression-free survival as compared to standard treatment options

Oct 31, 2023

Bookmark1. Median overall survival and progression-free survival were greater in the tebentafusp...

Deep learning models of ultrasonography effective in identifying superficial soft-tissue masses

Oct 31, 2023

Bookmark1. In this retrospective study, the use of deep learning models improved the accuracy of...

Cardio-oncology rehabilitation for cancer survivors promotes improvements in cardiorespiratory fitness — the CORE trial

Oct 27, 2023

Bookmark1. The CORE trial showed that a cardio-oncology rehabilitation program demonstrated...

Berzosertib Plus Topotecan vs Topotecan Alone in Relapsed Small Cell Lung Cancer

Oct 24, 2023

Bookmark1 .The progression-free survival in berzosertib with topotecan vs topotecan alone was not...

Multicancer early detection blood tests show promise but warrant further clinical evaluation

Oct 20, 2023

Bookmark1. One-third of patients with a cancer signal were correctly diagnosed to have cancer. 2....

Psychological resilience and spiritual well-being may be associated with supportive care needs in breast cancer patients

Oct 18, 2023

Bookmark1. In this cross-sectional study, there was a significant negative relationship between supportive care needs and spiritual well-being and between supportive care needs and psychological resilience in breast cancer...